The regulatory environment in Japan for generic drug development is complex and has undergone significant changes in recent years. This […]

The biopharmaceutical sector has made significant strides in developing and delivering effective drugs to improve health and combat diseases. However,

A robust drug patent portfolio is not just an asset—it’s a critical tool for success. As companies invest billions in

Protecting your intellectual property is paramount. Drug patent prosecution is a complex and critical process that can make or break

Flexibility has become more than just a buzzword – it’s a necessity. Contract Development and Manufacturing Organizations (CDMOs) are at

When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to outsource various stages of drug development and

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand

The generic drug market in the United States faces significant challenges, including price volatility, supply chain disruptions, and strategies employed